Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7233 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD4736 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD1643 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1096 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD1783 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD6578 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2214 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2213 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6068 |
Discontinued |
0.6986 |
Remote Similarity |
NPD7001 |
Phase 3 |
0.6979 |
Remote Similarity |
NPD1573 |
Approved |
0.6979 |
Remote Similarity |
NPD1575 |
Approved |
0.697 |
Remote Similarity |
NPD2096 |
Phase 2 |
0.697 |
Remote Similarity |
NPD2091 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD5017 |
Discontinued |
0.6952 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.6938 |
Remote Similarity |
NPD3947 |
Discontinued |
0.693 |
Remote Similarity |
NPD3389 |
Approved |
0.693 |
Remote Similarity |
NPD3393 |
Approved |
0.693 |
Remote Similarity |
NPD3394 |
Approved |
0.6923 |
Remote Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD2094 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD2092 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD2095 |
Phase 2 |
0.6916 |
Remote Similarity |
NPD3795 |
Approved |
0.6916 |
Remote Similarity |
NPD5888 |
Phase 2 |
0.6916 |
Remote Similarity |
NPD3794 |
Approved |
0.6907 |
Remote Similarity |
NPD750 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6827 |
Remote Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD1291 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD1618 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD482 |
Approved |
0.6751 |
Remote Similarity |
NPD749 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.6745 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6744 |
Remote Similarity |
NPD4614 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD1568 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD1996 |
Discontinued |
0.6726 |
Remote Similarity |
NPD8289 |
Discontinued |
0.6714 |
Remote Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.6699 |
Remote Similarity |
NPD6137 |
Clinical (unspecified phase) |
0.6698 |
Remote Similarity |
NPD5426 |
Phase 3 |
0.6698 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6698 |
Remote Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.6698 |
Remote Similarity |
NPD4051 |
Discontinued |
0.6684 |
Remote Similarity |
NPD1631 |
Approved |
0.6683 |
Remote Similarity |
NPD8304 |
Clinical (unspecified phase) |
0.6681 |
Remote Similarity |
NPD8372 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7470 |
Discontinued |
0.6667 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7944 |
Discontinued |
0.6667 |
Remote Similarity |
NPD180 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4427 |
Phase 2 |
0.6652 |
Remote Similarity |
NPD3280 |
Approved |
0.665 |
Remote Similarity |
NPD6665 |
Discontinued |
0.665 |
Remote Similarity |
NPD4524 |
Discontinued |
0.6637 |
Remote Similarity |
NPD6173 |
Approved |
0.6635 |
Remote Similarity |
NPD7817 |
Phase 1 |
0.6635 |
Remote Similarity |
NPD7727 |
Phase 2 |
0.6635 |
Remote Similarity |
NPD4848 |
Phase 1 |
0.6622 |
Remote Similarity |
NPD4086 |
Phase 1 |
0.662 |
Remote Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD8114 |
Approved |
0.662 |
Remote Similarity |
NPD8115 |
Approved |
0.6619 |
Remote Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.6619 |
Remote Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.6619 |
Remote Similarity |
NPD6999 |
Discontinued |
0.6616 |
Remote Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.6614 |
Remote Similarity |
NPD510 |
Phase 1 |
0.659 |
Remote Similarity |
NPD5475 |
Discontinued |
0.6589 |
Remote Similarity |
NPD7289 |
Clinical (unspecified phase) |
0.6582 |
Remote Similarity |
NPD1343 |
Approved |
0.6567 |
Remote Similarity |
NPD2481 |
Approved |
0.6567 |
Remote Similarity |
NPD2479 |
Phase 3 |
0.6561 |
Remote Similarity |
NPD7878 |
Phase 2 |
0.6556 |
Remote Similarity |
NPD1627 |
Clinical (unspecified phase) |
0.6555 |
Remote Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.6555 |
Remote Similarity |
NPD2290 |
Phase 3 |
0.6555 |
Remote Similarity |
NPD2289 |
Phase 3 |
0.6553 |
Remote Similarity |
NPD2544 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD1270 |
Approved |
0.6542 |
Remote Similarity |
NPD8169 |
Discontinued |
0.6542 |
Remote Similarity |
NPD6987 |
Phase 1 |
0.654 |
Remote Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD4011 |
Clinical (unspecified phase) |
0.6528 |
Remote Similarity |
NPD1630 |
Approved |
0.6522 |
Remote Similarity |
NPD569 |
Clinical (unspecified phase) |
0.6515 |
Remote Similarity |
NPD485 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6507 |
Remote Similarity |
NPD4602 |
Approved |
0.6507 |
Remote Similarity |
NPD7619 |
Phase 3 |
0.6507 |
Remote Similarity |
NPD7618 |
Phase 3 |
0.6505 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6498 |
Remote Similarity |
NPD3968 |
Approved |
0.6495 |
Remote Similarity |
NPD2511 |
Approved |
0.6494 |
Remote Similarity |
NPD3006 |
Discontinued |
0.6491 |
Remote Similarity |
NPD5022 |
Discontinued |
0.6485 |
Remote Similarity |
NPD9510 |
Approved |
0.6484 |
Remote Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.6483 |
Remote Similarity |
NPD8468 |
Phase 2 |
0.6481 |
Remote Similarity |
NPD3410 |
Approved |
0.6481 |
Remote Similarity |
NPD3411 |
Phase 2 |
0.6471 |
Remote Similarity |
NPD4851 |
Clinical (unspecified phase) |
0.6468 |
Remote Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.6465 |
Remote Similarity |
NPD7396 |
Approved |
0.6465 |
Remote Similarity |
NPD5901 |
Discontinued |
0.6459 |
Remote Similarity |
NPD460 |
Discontinued |
0.6456 |
Remote Similarity |
NPD4988 |
Discontinued |
0.6452 |
Remote Similarity |
NPD7665 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD7666 |
Phase 3 |
0.6447 |
Remote Similarity |
NPD7781 |
Approved |
0.6447 |
Remote Similarity |
NPD7780 |
Approved |
0.6442 |
Remote Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD2336 |
Approved |
0.6441 |
Remote Similarity |
NPD8326 |
Phase 3 |
0.6441 |
Remote Similarity |
NPD8325 |
Phase 3 |
0.6441 |
Remote Similarity |
NPD8327 |
Clinical (unspecified phase) |
0.6441 |
Remote Similarity |
NPD2787 |
Clinical (unspecified phase) |
0.6438 |
Remote Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.6436 |
Remote Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.6436 |
Remote Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.6435 |
Remote Similarity |
NPD3960 |
Clinical (unspecified phase) |
0.6432 |
Remote Similarity |
NPD5887 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD5088 |
Discontinued |
0.6425 |
Remote Similarity |
NPD7970 |
Approved |
0.6425 |
Remote Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD5510 |
Approved |
0.6422 |
Remote Similarity |
NPD6529 |
Discontinued |
0.6422 |
Remote Similarity |
NPD5596 |
Phase 2 |
0.6415 |
Remote Similarity |
NPD4987 |
Clinical (unspecified phase) |
0.6408 |
Remote Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.6404 |
Remote Similarity |
NPD6595 |
Phase 3 |
0.6395 |
Remote Similarity |
NPD4958 |
Clinical (unspecified phase) |
0.6393 |
Remote Similarity |
NPD6204 |
Clinical (unspecified phase) |
0.6392 |
Remote Similarity |
NPD820 |
Phase 3 |
0.639 |
Remote Similarity |
NPD7482 |
Phase 2 |
0.639 |
Remote Similarity |
NPD7483 |
Phase 2 |
0.6389 |
Remote Similarity |
NPD3247 |
Clinical (unspecified phase) |
0.6389 |
Remote Similarity |
NPD8272 |
Phase 2 |
0.6385 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.6384 |
Remote Similarity |
NPD6770 |
Approved |
0.6382 |
Remote Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.6377 |
Remote Similarity |
NPD4948 |
Discontinued |
0.6373 |
Remote Similarity |
NPD2061 |
Approved |
0.6372 |
Remote Similarity |
NPD6995 |
Phase 1 |
0.6368 |
Remote Similarity |
NPD4702 |
Approved |
0.6368 |
Remote Similarity |
NPD4703 |
Approved |
0.6364 |
Remote Similarity |
NPD7070 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD3915 |
Approved |
0.6359 |
Remote Similarity |
NPD2008 |
Discontinued |
0.6359 |
Remote Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.6359 |
Remote Similarity |
NPD3967 |
Approved |
0.6359 |
Remote Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.6355 |
Remote Similarity |
NPD1587 |
Approved |
0.6351 |
Remote Similarity |
NPD5293 |
Phase 2 |
0.6351 |
Remote Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.6351 |
Remote Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.6347 |
Remote Similarity |
NPD1600 |
Suspended |
0.6346 |
Remote Similarity |
NPD7233 |
Approved |
0.6346 |
Remote Similarity |
NPD7234 |
Approved |
0.6343 |
Remote Similarity |
NPD5487 |
Phase 1 |
0.6343 |
Remote Similarity |
NPD8072 |
Approved |
0.634 |
Remote Similarity |
NPD2893 |
Phase 3 |
0.634 |
Remote Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.6336 |
Remote Similarity |
NPD7952 |
Approved |
0.6336 |
Remote Similarity |
NPD7791 |
Approved |
0.6336 |
Remote Similarity |
NPD7789 |
Approved |
0.6336 |
Remote Similarity |
NPD7951 |
Approved |
0.6336 |
Remote Similarity |
NPD7950 |
Approved |
0.6336 |
Remote Similarity |
NPD7790 |
Approved |
0.6336 |
Remote Similarity |
NPD7953 |
Approved |
0.6335 |
Remote Similarity |
NPD3916 |
Clinical (unspecified phase) |
0.6335 |
Remote Similarity |
NPD3918 |
Approved |
0.6335 |
Remote Similarity |
NPD4852 |
Phase 2 |
0.6335 |
Remote Similarity |
NPD3917 |
Approved |
0.6333 |
Remote Similarity |
NPD4922 |
Phase 2 |
0.6333 |
Remote Similarity |
NPD4376 |
Phase 3 |
0.6332 |
Remote Similarity |
NPD7731 |
Approved |
0.6332 |
Remote Similarity |
NPD7730 |
Approved |
0.6332 |
Remote Similarity |
NPD4845 |
Discontinued |
0.6332 |
Remote Similarity |
NPD6292 |
Clinical (unspecified phase) |
0.6332 |
Remote Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.633 |
Remote Similarity |
NPD3839 |
Phase 2 |
0.633 |
Remote Similarity |
NPD3840 |
Phase 2 |
0.633 |
Remote Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.6327 |
Remote Similarity |
NPD9398 |
Clinical (unspecified phase) |
0.6324 |
Remote Similarity |
NPD201 |
Phase 2 |
0.6324
|
Remote Similarity |
NPD5473 |
Discontinued |